Orthostatic Hypotension Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Orthostatic Hypotension Market is segmented By Treatment (Norepinephrine Reuptake Inhibitors, Adrenergic Medications), By Patient Type (Neurogenic Orthostatic Hypotension, Non-neurogenic Orthostatic Hypotension), By Therapeutics (Gene Therapy, Dopamine Agonists), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.
Orthostatic Hypotension Market Size
Market Size in USD
CAGR7.2%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 7.2% |
| Market Concentration | High |
| Major Players | Lundbeck A/S, Theravance Biopharma, Brain Neurotherapy Bio, Inc., Ionis Pharmaceuticals, Inc., Alterity Therapeutics |
please let us know !
Orthostatic Hypotension Market Analysis
The orthostatic hypotension market is estimated to be valued at USD 1.93 Bn in 2024 and is expected to reach USD 3.15 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. The orthostatic hypotension market is witnessing positive growth owing to factors such as increasing incidences of Parkinson's disease, diabetes and hypertension. These conditions make high risk population prone to orthostatic hypotension.